Yan L. Guo

Chengjiao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study.

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study.

Journal: Blood cancer journal

Published: May 04, 2026

Impact of severe immunoparesis degree and duration on progression-free survival in newly diagnosed multiple myeloma: a retrospective cohort study of 258 patients.

Impact of severe immunoparesis degree and duration on progression-free survival in newly diagnosed multiple myeloma: a retrospective cohort study of 258 patients.

Journal: Frontiers in oncology

Published: March 16, 2026

Association of Serum AXL and Gas6 Levels with Clinical Outcomes in Non-Hodgkin Lymphoma Patients with Post-Chemotherapy Infection.

Association of Serum AXL and Gas6 Levels with Clinical Outcomes in Non-Hodgkin Lymphoma Patients with Post-Chemotherapy Infection.

Journal: Infection and drug resistance

Published: January 18, 2026

Clinical Characteristics and Prognosis of B-cell Acute Lymphoblastic Leukemia Patients with IKZF1 Deletion

Clinical Characteristics and Prognosis of B-cell Acute Lymphoblastic Leukemia Patients with IKZF1 Deletion

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Prognostic factors of patients with intravascular large B cell lymphoma: a multicenter study in China.

Prognostic factors of patients with intravascular large B cell lymphoma: a multicenter study in China.

Journal: Frontiers in oncology

Published: August 19, 2025

Which dominates recurrence: tumor or microenvironment?

Which dominates recurrence: tumor or microenvironment?

Journal: Journal of translational medicine

Published: July 12, 2025

Risk factors for thrombotic events in Philadelphia chromosome-negative myeloproliferative neoplasms: a retrospective analysis of 336 cases.

Risk factors for thrombotic events in Philadelphia chromosome-negative myeloproliferative neoplasms: a retrospective analysis of 336 cases.

Journal: Frontiers in oncology

Published: June 01, 2025

Clinical Effects of Pomalidomide-Based Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Clinical Effects of Pomalidomide-Based Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: May 06, 2025

Integrative Analysis of Cuproptosis-Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non-Small Cell Lung Cancer.

Integrative Analysis of Cuproptosis-Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non-Small Cell Lung Cancer.

Journal: Journal of cellular and molecular medicine

Published: November 12, 2024

Coexistence of nodal marginal zone B-cell lymphoma and multiple myeloma: A case report and literature review.

Coexistence of nodal marginal zone B-cell lymphoma and multiple myeloma: A case report and literature review.

Journal: Medicine

Published: January 26, 2022

A Retrotransposon Insertion in GhMML3_D12 Is Likely Responsible for the Lintless Locus li3 of Tetraploid Cotton.

A Retrotransposon Insertion in GhMML3_D12 Is Likely Responsible for the Lintless Locus li3 of Tetraploid Cotton.

Journal: Frontiers in plant science

Published: August 11, 2020

Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.

Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.

Journal: Science advances

Published: July 09, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026